Spaces:
Sleeping
Sleeping
Update app.py
Browse files
app.py
CHANGED
@@ -28,18 +28,18 @@ In the comparison between acupuncture and needle contact the former showed bette
|
|
28 |
In this study it was possible to measure the efficacy of the stimulation of only one point or area , which is an ideal model for research in acupuncture.
|
29 |
The auricular area we chose for stimulation was never used before for the purpose of relaxing masticatory muscles.
|
30 |
Acupuncture and needle contact for 10 seconds showed similar effects."""
|
31 |
-
example2 = """
|
32 |
-
A total of
|
33 |
Outcome measures included pain reduction and improvement in function scores and systemic inflammation markers .
|
34 |
-
Pain was assessed using the visual analog pain scale (
|
35 |
-
Secondary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index scores , patient global assessment ( PGA ) of the severity of knee OA , and
|
36 |
-
Serum levels of interleukin
|
37 |
-
There was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , PGA , and
|
38 |
-
The mean difference between treatment arms (
|
39 |
-
Further , there was a clinically relevant reduction in the serum levels of IL
|
40 |
-
These differences remained significant at
|
41 |
-
The Outcome Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society International responder rate was
|
42 |
-
Low-dose oral prednisolone had both a short-term and a longer sustained effect resulting in less knee pain , better physical function , and attenuation of systemic inflammation in older patients with knee OA ( ClinicalTrials.gov identifier
|
43 |
sample_list.append(example1)
|
44 |
sample_list.append(example2)
|
45 |
|
|
|
28 |
In this study it was possible to measure the efficacy of the stimulation of only one point or area , which is an ideal model for research in acupuncture.
|
29 |
The auricular area we chose for stimulation was never used before for the purpose of relaxing masticatory muscles.
|
30 |
Acupuncture and needle contact for 10 seconds showed similar effects."""
|
31 |
+
example2 = """To investigate the efficacy of 6 weeks of daily low-dose oral prednisolone in improving pain , mobility , and systemic low-grade inflammation in the short term and whether the effect would be sustained at 12 weeks in older adults with moderate to severe knee osteoarthritis ( OA ) .
|
32 |
+
A total of 125 patients with primary knee OA were randomized 1:1 ; 63 received 7.5 mg/day of prednisolone and 62 received placebo for 6 weeks .
|
33 |
Outcome measures included pain reduction and improvement in function scores and systemic inflammation markers .
|
34 |
+
Pain was assessed using the visual analog pain scale ( 0-100 mm ) .
|
35 |
+
Secondary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index scores , patient global assessment ( PGA ) of the severity of knee OA , and 6-min walk distance ( 6MWD ) .
|
36 |
+
Serum levels of interleukin 1 ( IL-1 ) , IL-6 , tumor necrosis factor ( TNF ) - , and high-sensitivity C-reactive protein ( hsCRP ) were measured .
|
37 |
+
There was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , PGA , and 6MWD at 6 weeks .
|
38 |
+
The mean difference between treatment arms ( 95 % CI ) was 10.9 ( 4.8-18 .0 ) , p < 0.001 ; 9.5 ( 3.7-15 .4 ) , p < 0.05 ; 15.7 ( 5.3-26 .1 ) , p < 0.001 ; and 86.9 ( 29.8-144 .1 ) , p < 0.05 , respectively .
|
39 |
+
Further , there was a clinically relevant reduction in the serum levels of IL-1 , IL-6 , TNF - , and hsCRP at 6 weeks in the intervention group when compared to the placebo group .
|
40 |
+
These differences remained significant at 12 weeks .
|
41 |
+
The Outcome Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society International responder rate was 65 % in the intervention group and 34 % in the placebo group ( p < 0.05 ) .
|
42 |
+
Low-dose oral prednisolone had both a short-term and a longer sustained effect resulting in less knee pain , better physical function , and attenuation of systemic inflammation in older patients with knee OA ( ClinicalTrials.gov identifier NCT01619163 ) ."""
|
43 |
sample_list.append(example1)
|
44 |
sample_list.append(example2)
|
45 |
|